Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: John McCarthy who wrote (172)	11/9/1997 6:22:00 PM
From: John McCarthy	Read Replies (1) \| Respond to of 569

Estimated BIOX 1997 E.P.S. is $1.36 and $0.17 for the Year and 4th Quarter, respectively. Full Year 1997 E.P.S. is: $1.36 ---- ---- Note: .23+.11+.85+.17 = $1.36 Below is my 4th qtr estimate for 1997. Per BIOX Sept 10Q, to receive $1,000 license fee from AHP in 4th qtr. 97. BIOX ------------------------- 4TH Qtr. 97 ------------------------- IBD JM -------- ------- Product Sales 5,367 7,000 License Fee AHP -0- 1,000 10Q Report -------- ------- Total Revenue 5,367 8,000 -------- ------- GM % .68 .68 GM $ - Product 3,650 4,760 GM $ - License Fee -0- 1,000 -------- ------- Total GM$ 3,650 5,760 -------- ------- R&D 1,575 1,575 G&A 2,150 2,150 -------- ------- Total R&D/G&A 3,725 3,725 -------- ------- Income from Oper <75> 2,035 -------- ------- Interest Income 190 190 -------- ------- EBT 115 2,225 -------- ------- Tax Prov % 10 10 Tax Prov $ 11 223 -------- ------- EAT 103 2,003 -------- ------- -------- ------- E.P.S .01 .17 -------- ------- -------- ------- SHARES 11,500 11,500 -------- ------- -------- ------- IBD = Investors Business Daily Regards, John McCarthy